Summary The aim of this study was to evaluate whether food intake modulates experimental tumour growth by acute alterations in the energy state and blood flow of the tumour, and if so whether such changes are related to alterations in the enzyme ornithinedecarboxylase (ODC) and DNA synthesis. Inbred mice (C57BL/ J) bearing a syngeneic undifferentiated and rapidly growing tumour were used. The tumour levels of high energy phosphates were measured in vivo by 31-P-NMR spectroscopy and biochemically following tissue extraction. DNA synthesis was estimated by measuring the incorporation of bromodeoxy-uridine into tumour DNA. Difluoro-methylornithine (DFMO) was used to inhibit ODC-activity. Tumour 
It is well known that DNA synthesis in malignant tumours is influenced by many factors, such as polyamines, growth factors, classical hormones, metabolites and drugs. It has been less recognised that nutrition and food intake is one of the most powerful modulators of tumour growth in various experimental systems (Torosian et al., 1984; Stragand et al., 1978; Sauer et al., 1986; Popp et al., 1981; Eden et al., 1983 ). Short periods of starvation, 12-24 h, will influence the growth curve in many solid tumours. This mechanism is important to understand, since 'therapeutical interventions' with drugs and cytokines, promoting anorexia, might then be misinterpreted to represent a more direct tumour influence. In line with this we recently concluded that factors interfering with the glucose homeostasis in tumour-bearing hosts can indirectly control tumour cell proliferation. This conclusion was also supported by the finding that the carbohydrate component in ordinary animal food pellets was a powerful stimulant of tumour cell proliferation by activating DNA synthesis, an effect which may be evoked by insulin (Westin et al., 1991a; Westin et al., 1991b) . Changes in tumour DNA synthesis was reflected by alterations in ornithinedecarboxylase activity (ODC), which is rate limiting for polyamine synthesis (Russel, 1973; Pegg, 1988; Ota et al., 1984; Janne et al., 1978) . Polyamines are probably endogenously produced growth factors, that without cell DNA synthesis and cellcycle traverse cannot proceed normally. Thus, up-and downregulation of ODC-activity was intimately related to tumour DNA synthesis, indirectly controlled by components in the food (Westin et al., 1991 a) . The understanding of these mechanisms is only in its infancy. Therefore, the aim of this study was 
Material and methods
Animal model Sex matched male and female mice (C57BI/6J) were used. All experiments were performed in 3 months old, weight-stable mice (20-25 g). A low-to undifferentiated tumour (MCG 101) , originally induced as a sarcoma by methylcholanthrene, was used as a transplantable syngeneic tumour graft. The tumour tissue was implanted subcutaneously in the flank by a trocar. This tumour does not metastasise when implanted subcutaneously and its influence on the host has been reported elsewhere (Edstrom et al., 1985; Lundholm et al., 1978; Lundholm et al., 1980) . Whole body energy expenditure is increased in these tumour-bearing mice accounting for decreased food intake, but body temperature is normal . Histological evaluation of tumour tissue, judged as being 'non-necrotic', has demonstrated a rather homogeneous capillary supply without areas of dead and lysed cells. The survival time of the tumour-bearing animals housed at + 25°C is 15-17 days and the cause of death has been evaluated elsewhere (Svaninger et al., 1989) .
The animals were kept in individual cages. They had free access to tap water and purina chow (Ewos, Astra, Sodertalje, Sweden), deficient in polyamines and with metabolisable energy of 13.0 MJ kg-' = 3.1 Mcal kg-'. Food intake (Lundholm et al., 1980) , changes in host body composition (Eden et al., 1983) and tumour-growth rate (Karlberg et al., 1981) have been reported. The animals were killed by cervical dislocation. In all experiments study and corresponding control animals were analysed at the same time and under identical conditions. Animals were lightly anaesthetised by i.p. injection of pentobarbital 0.06 mg g-' when necessary for the in vivo 3'P-NMR experiments. This procedure did not influence tumour blood flow evaluated in separate experiments. Blood flow measurements were performed with a '32Xe clearance technique (Mattsson et al., 1980 (PCr) , inorganic phosphate (Pi), phosphomonoesters (PME), phosphodiesters (PDE) and nucleotide triphosphate (NTP) were estimated from the computer integrated peak areas divided by the total phosphorus area (i.e. PCr + Pi + PME + PDE + a, P, y-NTP) (Soussi et al., 1990) . The P-NTP resonance has the largest contribution from the P-adenosine triphosphate (,B-ATP), (k 70%), it was therefore taken as a representative of the relative estimate of P-ATP content in the tissue and is referred to as ATP. The intracellular pH was determined from the chemical shift (6) of the Pi relative to the PCr using the following equation: pH = 6.75 + log [(6-3.27 )/(5.69-6)], (Gadian et al., 1983) . Initial experiments under different nutritional conditions using both in vivo (NMR) and in vitro (HPLC) techniques confirmed that the 3'P-NMR signal represented tumour tissue metabolism and that possible signals from other host tissues could be neglected even in small tumours. Thus, a PCr/ATP ratio of 1.5 ± 0.3 (HPLC) and 1.6 ± 0.6, (NMR) was calculated for tumour tissue. For skeletal muscle the PCr/ATP ratio was 3.1 ± 0.8; P <0.01.
High performance liquid chromatography (HPLC) Non necrotic parts of tumour tissue were rapidly obtained by surgical dissection and frozen in liquid nitrogen and freezedried for 8 h (LYOVAC GT 2, Leybold-Heraeus). Tumour tissue was then minced to a powder. To 15 mg dry powder 0.285 ml PCA (1.5 mM) containing 1 M EDTA was added and the extraction was performed by gentle agitation for 20 min on ice. The precipitate was separated by centrifugation and neutralised before injection into the HPLC (Pharmacia Fine Chemicals AB, Uppsala, Sweden) (Idstrom et al., 1990 ). The column used was a prepacked reversed phase C2/C18 Silca Column, Mino RPC S5/20 (5 rm; 4.6 x 200mm), (Pharmacia). The eluation medium mobile phase consisted of 0.1 M ammonium dihydrogen phosphate buffer (NH4H2PO4) with pH adjusted to 6.0 with 3 M ammonium hydroxide. The nucleotides, nucleosides, and purine bases, adenosinetriphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), inosine monophosphate (IMP), inosine (In), hypoxantine (Hx) and uric acid (Ua) as well as phosphocreatine (PCr) and creatine (Cr), were separated and concentrations were determined as described in details elsewhere (Soussi et al., 1990 ). The energy charge was calculated according to Atkinson (Atkinson, 1977) :
Incorporation of bromodeoxyuridine (BrdUrd) The method for BrdUrd incorporation into tumour DNA is described in detail elsewhere (Van Furth & Van Zwet, 1988; Sasaki et al., 1986; Gratzner, 1982) . Briefly, the incorporation of BrdUrd was accomplished by an i.p. injection of 0.1 mg g-' bw BrdUrd dissolved in 0.9% NaCl, one hour before sacrifice (Wilson et al., 1985) . Tumour (Westin et al., 1991a; Westin et al., 1991b) .
DFMO treatment (Experiment 3) by addition of 2% difluoromethylornithine to the drinking water caused a significant decrease in tumour weight, which was 1.5 ± 0.1 g in non-treated tumour animals compared to 1.0 ± 0.2 g in DFMO treated animals (P <0.05). There was, no significant difference in carcass weight (22.3 ± 0.5 g and 22.1 ± 0.6 g) between the two groups. There was no influence on water and food intake by DFMO. The tumour concentration of putrescine and spermidine decreased, while spermine concentration was unchanged by DFMO as reported elsewhere (Westin et al., 1991b ).
Tumour energy state
The energy state of the tumour was assessed by 3'P-NMR (in vivo) during tumour growth (Experiment 1), (Table I and Figure 2 ). The tumour was analysed with a size of 0.5-1 g on day 7 until a size of 4-6 g on day 15 just prior to animal death due to the tumour. During tumour progression the ATP/Pi and PCr/Pi were slightly reduced while the PME and the PDE levels were increased (Figure 2 ). There was no significant change in the tumour pH during tumour progression. (Table II vs III) . Thus, light pentobarbital anaesthesia had no effect on tumour content of high energy phosphates, (the in vitro determination of phosphates was done without prior use of anaesthesia). Starvation/refeeding was associated with alterations in tumour blood flow (Figure 1 Figure 1 Tumour blood flow in animals that were freely fed, then subjected to a period of 10 h complete starvation, and then refed again for 4 h. The decline in blood flow was significant at P<0.05. Blood flow was measured as described in Material and methods. Table III HPLC analysis of phosphocreatine, creatine, nucleotides, nucleosides and purine bases in tumour biopsy specimens from either tumour-bearing (TB) mice (on day 9) that were freely-fed (n = 8), starved for 24 h (n = 6) subsequently refed for 10 h (n = 6) or freely-fed DFMO-treated (n = 5). The results can be compared to in vivo measurements in Table II (Table III) . DNA-synthesis was estimated by bromodeoxy-uridine (BrdUrd) incorporation into tumour cell DNA. *P<0.05 vs ad lib (freelyfed tumour-bearing animals).
DFMO treatment (Experiment 3) caused a significant rise in the high energy phosphates (PCr, P <0.05 and ATP, P<0.08) measured both in vivo and in vitro. There was no significant difference in either pH or energy charge (0.63 ± 0.06) in DFMO-treated tumour-bearing groups compared to untreated control TB-animals (Tables II and  III) .
Tumour DNA synthesis Acute starvation decreased BrdUrd incorporation into DNA by 20% (P <0.01) and this attenuation was restored during subsequent refeeding. DFMO treatment decreased DNAsynthesis in tumour tissue (Figure 3 ).
Discussion
Previous experiments in our tumour model have demonstrated that the carbohydrate component in a standard chow diet initiates tumour DNA synthesis during refeeding which was probably not related to insulin (Westin et al., 1991a) .
The aim of this study was, therefore, to evaluate whether food intake and acute starvation modulate tumour growth and DNA synthesis indirectly by rapid alterations in the energy state of the tumour, since ATP and ADP are important elements in allosteric regulation of glycolysis and respiration. Polyamine synthesis inhibition was used as an alternative approach to decrease tumour DNA synthesis and thereby indirectly energy rich phosphates.
Our results demonstrate that the energy charge was significantly decreased in tumours on starved animals, while it rapidly returned to pre-starvation levels during refeeding. These findings confirm that the metabolism in rapidly growing experimental tumours are sensitive to acute changes in the host nutrition state. A nutrition related growthphenomenon in experimental tumours has also been illustrated indirectly by giving tumour-bearing rats intravenous nutrition, which resulted in a more rapid tumour growth compared to orally nourished tumour-bearing animals with anorexia (Torosian, 1984) . By this mechanism anorexia may be a counter-regulatory phenomenon to slow down tumour growth and thereby maximise survival. The present study suggests that nutrition-induced alterations in tumour growth are in part explained by alterations in tumour content of energy phosphates, probably related to a reduced tumour blood flow.
We have recently demonstrated that a decrease in DNA synthesis following starvation was preceded by a similar change in tumour ornithine-decarboxylase activity (ODC), (Westin et al., 1991 b) . ODC-activity can be irreversibly inhibited by DFMO (difluoro-methyl-ornithine), a substance which is under clinical evaluation for tumour treatment. In present experiments DFMO inhibited tumour growth as expected (Pegg, 1988) , as confirmed by a lower BrdUrd incorporation into DNA and a 35% decrease in tumour mass. It is important to emphasise that food intake was not decreased in DFMO-treated tumour-bearing animals. Therefore, we conclude that DFMO-inhibition of tumour growth was direct rather than indirect by altered nutrition and decreased availability of energy phosphates. In line with this theory, both ATP and PCr levels were increased and Pi decreased in tumour tissue during DFMO-inhibition of tumour growth. Therefore, we did not measure tumour blood flow in DFMO treated animals, since they did not show a decline in tumour high energy phosphates. The energy charge in tumour tissue was under all conditions significantly lower than 0.85, which suggests a different equilibrium for energy production/utilisation in tumour tissue than seen in normal tissues (Atkinson, 1977) . This is not to say that the metabolic rate was high in our tumours, but may rather represent a different equilibrium for energy flow compared to normal cells. We have previously confirmed that respiration and glycolysis is lower in these tumour cells than found in many normal cells (unpublished results). The overall tumour concentration of the high-energy phophates was also lower than seen in most normal tissues. This may to some extent depend on the fact that tumour tissue is composed of a mixture of cells with high and low viability. Another explanation may be that tumour profusion is heterogeneous and that tumour blood flow was considerably lower than found in normal tissues as liver and skeletal muscles (unpublished) . Blood flow is the major determinant of substrate and oxygen supply to the tissue. Insufficient tumour perfusion implicates poor substrate supply and low oxygen concentration which probably affects the tumour by reducing its energy state. Therapy induced decreases in the nucleotide triphosphates-to-Pi ratio have been attributed to decreased blood flow (Evelhoch et al., 1988) . However, necrosis will occur only when the ATP is depleted to monophosphates and further irreversibly degraded to nonphosphorylated products. In a study investigating the effects of the cytokine interleukin-a on RIF-1 tumours, necrosis appeared at least 12 h after an important reduction in phosphate metabolites (Constantinidis et al., 1989) .
Our findings of high energy phosphates in tumour tissue agree with previous results obtained by NMR spectroscopy on human (Daly & Cohen, 1989; Vaupel et al., 1989) and experimental tumours (Smith et al., 1989) . Major increases in Pi compared with the other phosphate resonances have been shown to be a result of tumour necrosis (Naruese et al., 1985) . The PME levels found to increase with tumour progression support the usefulness of this 31P NMR signal in monitoring tumour energetics. However, any AMP, IMP and sugar-phosphates formed would also contribute to the PME peak which contains contributions from phosphoethanolamine and phosphocholine. It should be pointed out that a direct comparison between the HPLC and the NMR data could be misleading since analysis of tissue extracts reflects total metabolite concentrations and not free cytosolic contents as by in vivo NMR. The PCr instability and its rapid breakdown to Pi and Cr is not avoidable in biochemical analysis. However, assessing this metabolite in vivo by NMR may correct for the usually lower extract values.
In conclusion, this study gives support to a direct role of ODC for induction or promotion of tumour cell division. A decrease in ODC-activity by DFMO (Pegg, 1988) led to inhibition of DNA-synthesis, but this decrease was not explained by a decreased availability of cellular energy. On the contrary, a lowered DNA synthesis following ODCinhibition by DFMO was associated with a rise in tumour energy rich phosphates probably secondary to a decreased energy demand for cell division. In contrast, a fall in DNA synthesis following starvation led to a decrease in tumour energy content perhaps related to a lower blood flow. Our findings give a rationale to suggest that force-feeding of energy-deprived tumours may stimulate tumour growth provided appropriate tumour oxygenation (Vaupel et al., 1989) . In this respect carbohydrate containing diets may be most detrimental (Westin et al., 1991a) . In other words, forcefeeding by glucose may activate ODC, which may induce DNA synthesis and thereby promote cell cycle traverse. These events may then give a more susceptible situation for cytocidal drug therapy. This hypothesis can now be systematically tested in experimental and clinical tumour systems.
